Table 2 The relationship between sleep disorders and mortality among cancer participants, NHANES(2005–2016)
Outcomes | Non-adjusted Model | Model I | Model II | |||
|---|---|---|---|---|---|---|
HR (95% CI) | P-value | HR (95% CI) | P-value | HR (95% CI) | P-value | |
Sleep disorders | ||||||
All-cause mortality No. of deaths/participants (1028/3187) | ||||||
Total | ||||||
No | 1(reference) | 1(reference) | 1(reference) | |||
Yes | 0.97(0.85, 1.11) | 0.66 | 1.27(1.11, 1.45) | < 0.001 | 1.23 (1.06, 1.42) | < 0.01 |
Male | ||||||
No | 1(reference) | 1(reference) | 1(reference) | |||
Yes | 1.28 (1.07, 1.52) | < 0.01 | 1.52 (1.27, 1.81) | < 0.001 | 1.47 (1.22, 1.77) | < 0.001 |
Female | ||||||
No | 1(reference) | 1(reference) | 1(reference) | |||
Yes | 0.80(0.65, 0.99) | 0.04 | 1.01 (0.82, 1.24) | 0.96 | 1.00(0.80, 1.25) | 1.00 |
Cancer mortality No. of deaths/ participants (347/3187) | ||||||
Total | ||||||
No | 1(reference) | 1(reference) | 1(reference) | |||
Yes | 1.09 (0.87, 1.37) | 0.45 | 1.33 (1.06, 1.67) | < 0.05 | 1.30 (1.02, 1.66) | < 0.05 |
Male | ||||||
No | 1(reference) | 1(reference) | 1(reference) | |||
Yes | 1.72 (1.30, 2.28) | < 0.001 | 1.88 (1.42, 2.49) | < 0.001 | 1.82 (1.34, 2.46) | < 0.001 |
Female | ||||||
No | 1(reference) | 1(reference) | 1(reference) | |||
Yes | 0.64 (0.43, 0.94) | 0.02 | 0.73(0.49, 1.09) | 0.12 | 0.74 (0.48, 1.14) | 0.17 |
CVD mortality No. of deaths/ participants (269/3187) | ||||||
Total | ||||||
No | 1(reference) | 1(reference) | 1(reference) | |||
Yes | 1.02(0.78, 1.33) | 0.88 | 1.47 (1.13, 1.92) | < 0.01 | 1.35 (1.02, 1.80) | < 0.05 |
Male | ||||||
No | 1(reference) | 1(reference) | 1(reference) | |||
Yes | 1.11 (0.78, 1.58) | 0.56 | 1.49 (1.05, 2.13) | < 0.05 | 1.49 (1.03, 2.16) | < 0.05 |
Female | ||||||
No | 1(reference) | 1(reference) | 1(reference) | |||
Yes | 1.10 (0.74, 1.65) | 0.63 | 1.45 (0.97, 2.18) | 0.07 | 1.22 (0.79, 1.89) | 0.37 |